Vaccinex receives Nasdaq delisting notice for bid price below $1.00

VACCINEX, INC.

Nasdaq letter on Oct 10, 2022: common stock bid price below $1.00 for 30 consecutive days through Oct 7.
Company has 180 days (until April 10, 2023) to regain compliance by closing at $1.00+ for 10 business days.
If not cured, may seek second 180-day period if meeting other listing standards; otherwise delisting risk.
Company to monitor bid price and evaluate options including reverse stock split to cure.
No immediate effect on listing; appeal rights exist if delisting notice issued.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.